Search

Search Constraints

You searched for: Author/Creator Mischel, Paul S.

Search Results

1. A phase I dose‐escalation study to assess safety, tolerability, pharmacokinetics, and preliminary efficacy of the dual mTORC1/mTORC2 kinase inhibitor CC‐223 in patients with advanced solid tumors or multiple myeloma. Issue 19 (15th July 2015)

9. Silencing of protein kinase D2 induces glioma cell senescence via p53-dependent and -independent pathways. Issue 7 (23rd January 2014)